News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
Views & Analysis A true story: Living with AIDS A 50-year-old man relates his personal experience of living with the condition.
News Gilead's next gen HIV prevention trial to begin in UK UK hospital seeking ethical clearance for trial of Gilead's new PReP drug.
News NICE review sparks new call for HIV prophylaxis NICE review backs case for Truvada pre-exposure prophylaxis, say campaigners.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
![iStock-497484764 [Converted]](https://pharmaphorum.com/wp-content/uploads/2016/11/world-aids-day-image.jpg)
